Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Chemicals
  4. Organic compounds
  5. Organoheterocyclic compounds
  6. Indoles and derivatives
  7. 167410

LE 300, Tocris Bioscience™

Catalog No. 167410 Shop All R&D Systems Products
Click to view available options
Quantity:
10 mg
This item is not returnable. View return policy
This item is not returnable. View return policy

Description

Potent and selective D1 antagonist

Potent and selective dopamine D1 receptor antagonist (Ki values are 0.08 - 1.9 nM and 6 - 45 nM for D1 and D2 receptors respectively). Also displays moderate affinity for the 5-HT2A receptor (Ki = 20 nM). Active in vivo.

Chemical Identifiers

CAS 274694-98-3
Molecular Formula C20H22N2
Molecular Weight (g/mol) 290.41
InChI Key YEWGIGCYIAMFMA-UHFFFAOYSA-N
Synonym 7-methyl-6,7,8,9,14,15-hexahydro-5h-benz d indolo 2,3-g azecine, 6,7,8,9,14,15-hexahydro-7-methyl-5h-indolo 3,2-f 3 benzazecine, 11-methyl-11,21-diazatetracyclo 12.7.0.0 3 ,?.0 1 ?, 2 ? henicosa-1 14 ,3,5,7,15,17,19-heptaene, tocris-1674, le 300, solid, lopac-l-8401, d07ylk, 7-methyl-6,7,8,9,14,15-hexahydro-5h-indolo 3,2-f 3-benzazecine, 7-methyl-6,7,8,9,14,15-hexahydro-5h-indolo 3,2-f 3 benzazecine, 7-methyl-6,7,8,9,14,15-hexahydro-5h-benzo 7,8 azecino 5,4-b indole le 300
PubChem CID 4350931
SMILES CN1CCC2=CC=CC=C2CC3=C(CC1)C4=CC=CC=C4N3

Specifications

Quantity 10 mg
Formula Weight 290.41
Percent Purity >98%
Chemical Name or Material LE 300

Safety and Handling

Recommended Storage Store at Room Temperature
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.